SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19

Main Article Content

Elisabetta Abruzzese
Hematology, S. Eugenio Hospital, Tor Vergata UniversityPiazzale dell’Umanesimo 1000144 Rome, Italy
http://orcid.org/0000-0001-5228-6491
Luigia Luciano
Hematology, Federico II Università, Napoli, Italy

Francesco D'Agostino
Hematology, Federico II Università, Napoli, Italy

Malgorzata Monika Trawinska
Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, Italy

Fabrizio Pane
Hematology, Federico II Università, Napoli, Italy

Paolo de Fabritiis
Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, Italy

Keywords

CML, SARS-CoV-2, COVID-19, TKI, ABL

Abstract

no abstract available


Aknowledgements:


We thank professor Nathan Tubliz, dept. Biology, University of Oregon, for his insightful support.

Downloads

Download data is not yet available.


Abstract 2541
PDF Downloads 1171
HTML Downloads 303

Article Sidebar

PDF HTML
Published
Apr 27, 2020
DOI https://doi.org/10.4084/mjhid.2020.031

Article Details

How to Cite

Abruzzese, E. (2020) “SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection: CML and COVID-19 ”, Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020031. doi: 10.4084/mjhid.2020.031.
Issue
Vol. 12 No. 1 (2020): Mediterranean Journal of Hematology and Infectious Diseases, Volume 12, 2020
Section
Letters to the Editor

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.